Hydroxychloroquine approved in Italy: the full scientific report
This report forms the scientific basis for the decision to authorise hydroxychloroquine in the treatment of Covid-19 in the early phase of the disease.
This report forms the scientific basis for the decision to authorise hydroxychloroquine in the treatment of Covid-19 in the early phase of the disease.
We will introduce, within our ‘Covid at home’ protocol, the use of hydroxychloroquine; it can be used by doctors according to science and conscience.